1. Home
  2. ASTI vs SCYX Comparison

ASTI vs SCYX Comparison

Compare ASTI & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$3.07

Market Cap

40.9M

Sector

Technology

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$3.57

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
SCYX
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.9M
42.4M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ASTI
SCYX
Price
$3.07
$3.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$20.00
$3.00
AVG Volume (30 Days)
376.9K
82.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
70.23
61.36
EPS
N/A
N/A
Revenue
$10,398,149.00
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$608.78
P/E Ratio
N/A
N/A
Revenue Growth
163.25
N/A
52 Week Low
$1.40
$0.57
52 Week High
$9.87
$5.62

Technical Indicators

Market Signals
Indicator
ASTI
SCYX
Relative Strength Index (RSI) 30.41 42.77
Support Level $1.42 $0.66
Resistance Level $4.68 $5.10
Average True Range (ATR) 0.28 0.38
MACD -0.02 -0.16
Stochastic Oscillator 4.36 7.14

Price Performance

Historical Comparison
ASTI
SCYX

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: